GST Input Tax Credit and How It Reshapes Hospital Buying

Almost no hospital is entirely exempt. There is usually some taxable revenue, and where inputs are used partly for taxable and partly for exempt supplies, the common credit has to be apportioned. Rules 42 and 43 of the CGST Rules set out the mechanics: identify credit attributable exclusively to exempt supplies and block it, identify credit attributable exclusively to taxable supplies and keep it, and apportion the remaining common credit in the ratio of exempt turnover to total turnover.

Rule 42 handles inputs and input services on a monthly basis with an annual reconciliation. Rule 43 handles capital goods, spreading the credit over a defined useful life and reversing the exempt share month by month across that period. The practical effect for a hospital with a small taxable sliver is that the overwhelming majority of common credit reverses, and the remaining credit is not large enough to change a buying decision.

The compliance burden, though, is real regardless of the size of the benefit. The apportionment has to be computed monthly, the annual reconciliation has to be done, and interest attaches to shortfalls. Hospitals that treat the exercise as trivial because the recoverable amount is small end up with a mechanical calculation error that carries interest across several years. Get the working papers right even when the number is unexciting.

Most hospitals have some taxable turnover, and it is worth knowing exactly what yours is, because it sets your credit ratio and it drives several thresholds. Outpatient pharmacy sales to walk-in customers, canteen and cafeteria, rented commercial space in the building, parking, certain cosmetic procedures that fall outside the exemption for health care services, and equipment or space hired out to third parties are the usual candidates.

The line between exempt health care and taxable service is not always obvious, and the treatment of medicines and food supplied to an admitted patient as part of a composite supply of health care has been the subject of considerable advance ruling activity. This is genuinely an area where a documented position from your tax advisor, revisited annually, is worth more than an internal interpretation. Where a position is taken, write down the reasoning and the authority relied on.

Room charges deserve a specific mention because the treatment has moved. Charges for rooms above a notified threshold in non-intensive-care settings were brought within the tax net in 2022 and the position has been revisited since. Do not run your billing configuration on a rule someone set three years ago. Confirm the current notification each time your rate card changes, because the configuration and the rate card are usually changed by different people.

When credit is available, the choice between buying and leasing turns mainly on cost of capital. When credit is blocked, tax becomes part of the comparison and can invert the answer. Outright purchase concentrates the tax into a single capital outlay. A lease spreads it across monthly rentals, and if the rental attracts a different rate from the equipment itself, the total tax cost over the life differs even when the pre-tax economics are identical.

Reagent rental and pay-per-test arrangements deserve particular scrutiny for the same reason. In these models the analyser arrives at nominal or zero cost and the value is recovered through consumable pricing over several years. Where the consumable attracts a lower rate than the equipment, the structure is genuinely cheaper on a tax-inclusive basis. Where it does not, you may simply be financing the machine at an unfavourable implicit interest rate with tax on top.

The discipline is to model both routes over the full expected life, tax-inclusive, with the consumable volumes you actually expect rather than the volumes the vendor's model assumes. Vendors build pay-per-use proposals on optimistic throughput because throughput is what makes their return. Rebuild the same model on your own last twelve months of test volumes and the ranking often changes.

Annual maintenance contracts attract service tax rates that a hospital largely cannot recover, which makes AMC negotiation a tax-inclusive negotiation. The point is not to find a clever structure that avoids tax; it is to compare offers correctly and to avoid structures that inflate the taxable value without adding value to you. A comprehensive contract bundling parts and labour into a single service value is taxed differently from a labour-only contract with parts billed on supply, and the difference is real money over five years.

Reverse charge is the quiet one. Where a hospital receives services such as goods transport, legal services, security services or sponsorship from certain categories of supplier, the tax liability sits on the hospital. You pay it, you account for it, and because your output is exempt you generally cannot use the resulting credit. Materials teams negotiating a security or transport contract on a rate that ignores the reverse charge cost are negotiating the wrong number.

Also check who bears tax on free-of-cost supplies and on replacements under warranty, because the treatment of goods moving without consideration is not intuitive and vendors sometimes pass a cost back to you contractually that you did not price. Read the tax clause in the AMC as carefully as the response-time clause. It is the clause most likely to have been copied from a template written for a taxable industry.

The recurring proposal is to hive the outpatient pharmacy into a separate registration or a separate legal entity so that its taxable sales carry a clean, unblocked credit chain on pharmacy purchases. On the pharmacy side the logic holds. Purchases attributable to taxable outpatient sales support credit, the apportionment becomes simpler, and the pharmacy operates like the retail business it substantially is.

The cost is on the hospital side and it is usually underestimated. Medicines the pharmacy entity supplies to the hospital for admitted patients become a supply between two persons, valued under the related-party rules, taxed, and then blocked in the hospital's hands because the hospital's output is exempt. Depending on the ratio of inpatient to outpatient dispensing, the structure can leave you worse off than the arrangement it replaced.

There is also a compliance and operational cost that never appears in the tax note: two item masters that drift apart, two sets of stock records, inter-entity documentation on every transfer, and a materials team maintaining a boundary that clinicians will ignore in an emergency. Model the structure on your actual dispensing split before you commit to it, and revisit it if that split moves. Where a hospital does run the separation, a single inventory platform holding both entities with a clear transfer trail is what keeps the boundary auditable rather than theoretical.

The trap that catches hospitals is aggregate turnover. It includes exempt supplies, not just taxable ones, which means a hospital whose revenue is almost entirely exempt can still cross registration and e-invoicing thresholds on the strength of that exempt revenue. Finance teams who reason from taxable turnover alone routinely conclude a threshold does not apply to them when it does.

The practical consequences are administrative rather than financial. Exempt supplies are documented through a bill of supply rather than a tax invoice, and e-invoicing applies to the taxable business-to-business supplies you make once you are over the threshold. For most hospitals that is a small set of transactions — corporate health check packages, referred diagnostics, space rental — but a small set of transactions done wrong still produces a mismatch that has to be explained.

Multi-branch groups have an additional layer, since registration is state-wise and branches in different states are distinct persons for GST. Stock transfers between them are supplies. A group that moves consumables between a hospital in one state and a hospital in another without documenting the transfer as a supply has created a discrepancy that will surface when the returns are reconciled, and the reconciliation almost always happens later than anyone would like.